391 related articles for article (PubMed ID: 10660809)
1. Parathyroid hormone-related protein, parathyroid hormone, and vitamin D in hypercalcemia of malignancy.
Motellón JL; Javort Jiménez F; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
Clin Chim Acta; 2000 Jan; 290(2):189-97. PubMed ID: 10660809
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
3. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid hormone (PTH)-related protein, PTH, and 1,25-dihydroxyvitamin D in dogs with cancer-associated hypercalcemia.
Rosol TJ; Nagode LA; Couto CG; Hammer AS; Chew DJ; Peterson JL; Ayl RD; Steinmeyer CL; Capen CC
Endocrinology; 1992 Sep; 131(3):1157-64. PubMed ID: 1505457
[TBL] [Abstract][Full Text] [Related]
5. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two immunoradiometric assays for parathyroid hormone-related protein in the evaluation of cancer patients with and without hypercalcemia.
de Miguel F; Motellón JL; Hurtado J; Jiménez FJ; Esbrit P
Clin Chim Acta; 1998 Oct; 277(2):171-80. PubMed ID: 9853700
[TBL] [Abstract][Full Text] [Related]
7. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.
Burtis WJ; Brady TG; Orloff JJ; Ersbak JB; Warrell RP; Olson BR; Wu TL; Mitnick ME; Broadus AE; Stewart AF
N Engl J Med; 1990 Apr; 322(16):1106-12. PubMed ID: 2320080
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer associated with hypercalcemia induced by concurrently elevated parathyroid hormone and parathyroid hormone-related protein levels.
Uchimura K; Mokuno T; Nagasaka A; Hayakawa N; Kato T; Yamazaki N; Kobayashi T; Nagata M; Kotake M; Itoh M; Tsujimura T; Iwase K
Metabolism; 2002 Jul; 51(7):871-5. PubMed ID: 12077733
[TBL] [Abstract][Full Text] [Related]
9. Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia.
Ratcliffe WA; Hutchesson AC; Bundred NJ; Ratcliffe JG
Lancet; 1992 Jan; 339(8786):164-7. PubMed ID: 1346019
[TBL] [Abstract][Full Text] [Related]
10. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.
Horwitz MJ; Tedesco MB; Sereika SM; Syed MA; Garcia-Ocaña A; Bisello A; Hollis BW; Rosen CJ; Wysolmerski JJ; Dann P; Gundberg C; Stewart AF
J Bone Miner Res; 2005 Oct; 20(10):1792-803. PubMed ID: 16160737
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.
Schilling T; Pecherstorfer M; Blind E; Leidig G; Ziegler R; Raue F
J Clin Endocrinol Metab; 1993 Mar; 76(3):801-3. PubMed ID: 8445039
[TBL] [Abstract][Full Text] [Related]
12. Raised plasma concentrations of parathyroid hormone related peptide in hypercalcemic multiple myeloma.
Horiuchi T; Miyachi T; Arai T; Nakamura T; Mori M; Ito H
Horm Metab Res; 1997 Sep; 29(9):469-71. PubMed ID: 9370119
[TBL] [Abstract][Full Text] [Related]
13. Malignancy-associated hypercalcaemia: resolution of controversies over vitamin D metabolism by a pathophysiological approach to the syndrome.
Schweitzer DH; Hamdy NA; Frölich M; Zwinderman AH; Papapoulos SE
Clin Endocrinol (Oxf); 1994 Aug; 41(2):251-6. PubMed ID: 7923831
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations.
Walls J; Ratcliffe WA; Howell A; Bundred NJ
Clin Endocrinol (Oxf); 1994 Oct; 41(4):407-13. PubMed ID: 7955450
[TBL] [Abstract][Full Text] [Related]
15. Levels of parathyroid hormone-related protein in hypercalcemia of malignancy: comparison of midregional radioimmunoassay and two-site immunoradiometric assay.
Blind E; Raue F; Meinel T; Bucher M; Manegold C; Ebert W; Vogt-Moykopf I; Ziegler R
Clin Investig; 1993 Jan; 71(1):31-6. PubMed ID: 8453257
[TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
17. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
[TBL] [Abstract][Full Text] [Related]
18. Relationship of plasma bone cytokines with hypercalcemia in cancer patients.
Motellón JL; Jiménez FJ; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
Clin Chim Acta; 2000 Dec; 302(1-2):59-68. PubMed ID: 11074064
[TBL] [Abstract][Full Text] [Related]
19. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
Haq M; Kremer R; Goltzman D; Rabbani SA
J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
[TBL] [Abstract][Full Text] [Related]
20. The clinical utility of parathyroid hormone-related peptide in the assessment of hypercalcemia.
Fritchie K; Zedek D; Grenache DG
Clin Chim Acta; 2009 Apr; 402(1-2):146-9. PubMed ID: 19168044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
